RxDoctor Payments Data

Robert Young, MD

Neuroradiology · New York, NYNPI 1104891548

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Telix Pharmaceuticals at 34.1% of the total.

$6,165in general payments, 2019–2025

Across 19 payments — averaging $324.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Telix Pharmaceuticals$2K
  • Turing Medical Technologies$2K
  • Olea Medical$1K
  • Guerbet LLC$1K
  • Servier Pharmaceuticals LLC$125

What the payments were for

  • Consulting fees$3,55058%
  • Speaking & faculty fees$1252%
  • Travel & lodging$1,26120%
  • Food & beverage$1,22820%

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Telix Pharmaceuticals12$2,103
Turing Medical Technologies1$1,575
Olea Medical2$1,225
Guerbet LLC3$1,137
Servier Pharmaceuticals LLC1$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,165 in reported general payments places this provider in the 75th percentile of 71 neuroradiology providers in New York.

See all neuroradiology providers in New York

Medicare billing

Part B allowed, 2024
$233,939
Medicare patients
1,400
Services billed
2,611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuroradiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →